Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Millan

Showing results (1-10 of 496) with videos related to

Pageof 50
Sort By:
Medecine Tropicale : Revue Du Corps De Sante Colonial|July 1, 1980
[Leprosy control in Guadeloupe (French West Indies). II. Rules of treatment and monitoring in "Grande Terre" district (author's transl)]J Millan
Medecine Tropicale : Revue Du Corps De Sante Colonial|July 1, 1980
[Leprosy control in Guadeloupe (French West Indies). I General organization notification and registration of patients (author's transl)]J Millan
Medecine Tropicale : Revue Du Corps De Sante Colonial|March 1, 1980
[Detection of leprosy in a district of Guadeloupe (F.W.I.). Organisation and evaluation (1973-1978) (author's transl)]J Millan
Neuropharmacology|December 19, 2012
An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapyMark J Millan
Pharmacology & Therapeutics|March 9, 2006
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic applicationMark J Millan
Progress in Neurobiology|May 30, 2002
Descending control of painMark J Millan
European Journal of Pharmacology|May 14, 1992
Evidence that an alpha 2A-adrenoceptor subtype mediates antinociception in miceM J Millan
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptorsM J Millan
Dialogues in Clinical Neuroscience|November 4, 2014
The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?Mark J Millan
Therapeutic Advances in Psychopharmacology|July 7, 2022
Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of actionMark J Millan
Pageof 50

Showing results (1-10 of 496) with videos related to

Sort By:
Pageof 50
Medecine Tropicale : Revue Du Corps De Sante Colonial|July 1, 1980
[Leprosy control in Guadeloupe (French West Indies). II. Rules of treatment and monitoring in "Grande Terre" district (author's transl)]J Millan
Medecine Tropicale : Revue Du Corps De Sante Colonial|July 1, 1980
[Leprosy control in Guadeloupe (French West Indies). I General organization notification and registration of patients (author's transl)]J Millan
Medecine Tropicale : Revue Du Corps De Sante Colonial|March 1, 1980
[Detection of leprosy in a district of Guadeloupe (F.W.I.). Organisation and evaluation (1973-1978) (author's transl)]J Millan
Neuropharmacology|December 19, 2012
An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapyMark J Millan
Pharmacology & Therapeutics|March 9, 2006
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic applicationMark J Millan
Progress in Neurobiology|May 30, 2002
Descending control of painMark J Millan
European Journal of Pharmacology|May 14, 1992
Evidence that an alpha 2A-adrenoceptor subtype mediates antinociception in miceM J Millan
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptorsM J Millan
Dialogues in Clinical Neuroscience|November 4, 2014
The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?Mark J Millan
Therapeutic Advances in Psychopharmacology|July 7, 2022
Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of actionMark J Millan
Pageof 50